Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
---|
05/06/2005 | CA2542898A1 Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents |
05/06/2005 | CA2542426A1 Methods, compositions and devices for inducing stasis in cells |
05/06/2005 | CA2542412A1 Use of xenon for the prevention of programmed cell death |
05/06/2005 | CA2528805A1 Gsk-3 inhibitors and uses thereof |
05/05/2005 | US20050096388 Compositions and methods for treating or preventing diseases of body passageways |
05/05/2005 | US20050096314 Treatment of cancers with methylol-containing compounds and at least one electrolyte |
05/05/2005 | US20050096304 Method of treating cancer using dithiocarbamate derivatives |
05/05/2005 | US20050095283 Administering antitumor and/or anticarcinogenic agent such as a paclitaxel or taxane derivative formulated in a liposome; Kaposi's sarcoma |
05/05/2005 | US20050095262 Multivitamin syrup for children or young adults |
05/05/2005 | US20050095232 Vaginal care composition |
05/05/2005 | US20050095226 Down-regulation of DNA repair to enhance sensitivity to p53-mediated suppression |
05/05/2005 | US20050095218 Wetting and applying to hair or skin with water; rinsing |
05/04/2005 | EP1526895A2 Methods for treating carbonic anhydrase mediated disorders |
05/04/2005 | EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
05/04/2005 | EP1465504B1 Matrix-forming composition containing pectin |
05/04/2005 | EP1220676B1 Prevention of colorectal cancer |
05/04/2005 | EP1206256B1 Combination therapy using pentafluorobenzenesulfonamide and platin compound |
05/04/2005 | DE20023649U1 Synergistic active agent combination of colostrum product, minerals and herbal component, useful as or in medicaments, foodstuffs, food supplements or cosmetics, e.g. for skin treatment |
05/04/2005 | CN1612742A Composition and method |
05/04/2005 | CN1612740A Cardiac arrest fluid |
05/04/2005 | CN1612731A Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases |
05/04/2005 | CN1612723A Local compositions containing enzymes stabilized with inhibitors |
05/04/2005 | CN1199674C Douching lotion for treating women's genital system disease |
05/04/2005 | CN1199670C Chinese medicine for treating leukodema |
05/04/2005 | CN1199669C Medicine for curing cervicitis and preparing method thereof |
05/04/2005 | CN1199666C Powdered medicine for treating intractable ulcer |
05/04/2005 | CN1199660C Powdered medicnie 'shaotangsan' for treating burn and scald |
05/04/2005 | CN1199657C Anticancer ointment |
05/03/2005 | US6888016 For therapy of insulin resistance; for stimulating the glucose up-take in adipocytes |
05/03/2005 | US6887894 Use of lipoic acid for improving the bioavailability of mineral salts |
05/03/2005 | US6887500 Compositions for lowering blood pressure |
05/03/2005 | US6887497 Composition for the treatment and prevention of osteoarthritis, rheumatoid arthritis and improved joint function |
05/03/2005 | US6887492 Magnesium plus interactive agent delivery |
05/03/2005 | US6887485 Silanized stainless steel surface coupled to nucleophilic amine residues then reacted with nitric oxide gas |
05/03/2005 | US6887458 Bead comprising mixture of polyvinyl alcohol and platinum (and titania) isotoped by neutron radiation; anticarcinogenic and antitumor agents |
05/03/2005 | CA2486473A1 Vaginal care composition |
05/03/2005 | CA2390636C Stabilized formulations comprising amlodipine maleate |
04/28/2005 | WO2005038042A2 Systems and methods for assessing neuronal degeneration |
04/28/2005 | WO2005037327A2 Chlorine dioxide gel and associated methods |
04/28/2005 | WO2005037296A1 Anti-coronavirus agent |
04/28/2005 | WO2005037295A1 Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s) |
04/28/2005 | WO2005037290A1 Use of phosphono derivatives as anti-malarial |
04/28/2005 | WO2005037259A2 Methods and compositions for the prevention or treatment of neoplasia comprising a cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist |
04/28/2005 | WO2005037255A1 Tablet with aqueous based-sustained release coating |
04/28/2005 | WO2005037219A2 Disinfecting teat care compositions |
04/28/2005 | WO2005037188A2 Therapeutic agent for periodontal disease |
04/28/2005 | WO2005016284A3 Gloves containing dry powdered aloe and method of manufacturing |
04/28/2005 | WO2005007115A3 Pharmaceutical composition for inhibiting acid secretion |
04/28/2005 | WO2004071437A3 Compositions for enhancing sexual responsiveness |
04/28/2005 | US20050090480 preventing malaria comprising administering drugs that inhibition of growth of the malarial parasite, plasmodium falciparum, along with phosphono derivatives and/or other drugs; parasiticides |
04/28/2005 | US20050089581 Applying a therapeutically effective amount of a magnesium-containing composition to the individual's skin, the magnesium-containing composition comprising about 25 to 35 weight percent magnesium chloride, a solvent, a gelling agent and glycerin |
04/28/2005 | US20050089580 Antibacterial glass composition, antibacterial resin composition and method for producing the same |
04/28/2005 | US20050089511 Methods and compositions comprising DNA damaging agents and p53 |
04/28/2005 | US20050089485 Sulfacetamide formulations for treatment of rosacea |
04/28/2005 | US20050089481 Composition for caries prevention |
04/28/2005 | CA2542795A1 Systems and methods for assessing neuronal degeneration |
04/28/2005 | CA2542634A1 Disinfecting teat care compositions |
04/28/2005 | CA2542337A1 Cancer gene therapeutic drug |
04/28/2005 | CA2542335A1 Cancer gene therapeutic drug |
04/27/2005 | EP1525886A1 Absorbent for oral administration, and agent for treating or preventing renal or liver disease |
04/27/2005 | EP1525878A1 Composition for caries prevention |
04/27/2005 | EP1524986A1 Metal cluster nano-compounds for treating tumor diseases |
04/27/2005 | EP1429628B1 Mixture of base-containing micronutrient substances |
04/27/2005 | EP1143974B1 Pharmaceutical compositions for alleviating discomfort |
04/27/2005 | EP0984776B1 Compositions and methods for inhibiting nematocyst discharge |
04/27/2005 | EP0893949B1 Use of antioxidant agents to treat cholestatic liver disease |
04/27/2005 | CN1610695A Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
04/27/2005 | CN1610536A Composition in the form of an emulsion that can be used to treat plantar bromhidrosis and/or hyperhidrosis |
04/27/2005 | CN1610506A Center-filled chewing gum containing calcium |
04/27/2005 | CN1608630A New use of hydrazine hydrate in treating tinea unguium |
04/27/2005 | CN1198659C Medical preparation, its preparing method and use in preparing medicine for accelerating collagen regeneration |
04/27/2005 | CN1198635C Chinese medicine haemorrhoids ointment |
04/27/2005 | CN1198627C Activator and inhibitor of profibrinolysin and agent of external use for skin for mating it |
04/27/2005 | CN1198626C Method and system for production and collection of lavage induced stool (LIS) for chemical and biologic tests of cells |
04/27/2005 | CN1198616C Oral formulations for anti-tumor compounds |
04/26/2005 | US6884440 Sodium metasilicate, borax,sodium thiosulfate, potassium carbonate, refined cane sugar and water; improvement in disease resistance, weight gain rate, crop yield, crop quality, and harvest time |
04/26/2005 | US6884439 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
04/26/2005 | US6884420 Antidiabetic agents contains Agaricus blazeii, alpha lipoic acid, transfer factor, polymannose, fenugreek, coenzyme Q-10, selenium, zinc, vitamin C, vitamin E, chromium and vanadium |
04/26/2005 | CA2326072C Condensate of sar abolisher, producing method thereof, and sar abolisher powder |
04/26/2005 | CA2144728C Method of treating premenstrual syndrome symptomatology with vitamin d or vitamin d and calcium |
04/23/2005 | CA2485836A1 Composition for caries prevention |
04/21/2005 | WO2005034968A1 Solution for cessation of smoking and method to use |
04/21/2005 | WO2005034967A1 Pharmaceutical or cosmetic compositions for treating skin |
04/21/2005 | WO2005034966A1 Use of xenon with hypothermia for treating neonatal asphyxia |
04/21/2005 | WO2005034912A2 Ferromagnetic particles and methods |
04/21/2005 | WO2005034883A2 A method of healing skin wounds in mammals and a composition therefor |
04/21/2005 | WO2005034728A2 Colon cleansing composition and method |
04/21/2005 | WO2005004884A3 Use of nitrite salts for the treatment of cardiovascular conditions |
04/21/2005 | WO2003061584A3 Novel substituted benzimidazole dosage forms and method of using same |
04/21/2005 | WO2003056951A3 Antimicrobial body covering articles |
04/21/2005 | US20050085454 Prevention, management of diabetes in humans, primates; plant extracts |
04/21/2005 | US20050085416 Stabilized albumin, fatty acid complex; anticancer agents; bactericides |
04/21/2005 | US20050084542 Osteoinductive bone material |
04/21/2005 | US20050084531 A tablet core of highly water-soluble active ingredient, e.g.,potassium chloride having an aqueous-based, dried coating of ethyl acrylate-methyl methacrylate copolymer of 0.5%-1.17% by weight after a greatly shortened drying time (30 minat 50 degrees C.); stable release profile; solvent-free; efficiency |
04/21/2005 | CA2540147A1 Colon cleansing composition and method |
04/21/2005 | CA2539868A1 A method of healing skin wounds in mammals and a composition therefor |
04/21/2005 | CA2538104A1 Use of xenon with hypothermia for treating neonatal asphyxia |
04/20/2005 | EP1523997A1 A medical dressing comprising an antimicrobial silver compound |
04/20/2005 | EP1523985A1 Strontium agent and method for treating cancer |
04/20/2005 | EP1523984A1 Pharmaceutical composition comprising oxoplatin, salts and derivatives thereof |